- According to estimates from 9 analysts, Altimmune, Inc. stock's average price target has risen from $16.89 to $17.22, with forecasts ranging from $11 to $28 per share
- Based on the Jul. 27 closing price, the updated target implies approximately 482% potential upside
- Consensus rating remains at “Buy” across 10 covering analysts, with 9 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Altimmune, Inc. on the , and track all previous and future analyst recommendations for Altimmune, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.